Brennan Daniel J. — SEC insider filings
SEC reporting owner CIK 1595612. 46 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers all 46 filings on record, filed 2021-01-05 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 13 filings — 497,623 shares, $32,132,091 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 164.
- Largest priced transaction: sale of 67,333 shares @ $105.24 ($7,086,111) in BOSTON SCIENTIFIC CORP, filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BOSTON SCIENTIFIC CORP (BSX) | EVP and CFO | 33 | — | 19 legs · 497,623 sh · $32,132,091 | 143 |
| WATERS CORP /DE/ (WAT) | Director | 6 | — | — | 12 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 2 | — | — | 4 |
| Nuance Communications, Inc. (NUAN) | Director | 3 | — | — | 4 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | Director | 2 | — | — | 1 |
Insider filings — Brennan Daniel J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 3 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Holdings only — no transactions reported | EDGAR |
| 2026-10-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 795 @ $503.47 | EDGAR |
| 2026-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 404 @ $0 · Grant/award (A): 681 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 23 @ $0 · Grant/award (A): 57 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 307 @ $0 · Grant/award (A): 828 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 967 @ $0 · Grant/award (A): 1,705 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Sale (S): 2,900 @ $104.08 · Sale (S): 14,630 @ $104.67 · Option exercise (M): 18,533 @ $24.55 · Option exercise (M): 16,865 @ $17.26 · Option exercise (M): 15,642 @ $27.09 · Option exercise (M): 9,483 @ $40.12 · +5 more | EDGAR |
| 2025-02-18 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,362 @ $0 · Tax withholding (F): 2,110 @ $106.11 · Option exercise (M): 4,243 @ $0 · Tax withholding (F): 2,052 @ $106.11 · Option exercise (M): 4,584 @ $0 · Tax withholding (F): 2,217 @ $106.11 · +5 more | EDGAR |
| 2025-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,654 @ $0 · Tax withholding (F): 1,767 @ $105.77 · Option exercise (M): 3,654 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 33,944 @ $0 · Tax withholding (F): 16,414 @ $105.98 · Option exercise (M): 15,087 @ $16.31 · Sale (S): 15,087 @ $105.07 · Option exercise (M): 15,087 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 319 @ $0 · Grant/award (A): 818 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 14,901 @ $0 · Tax withholding (F): 5,212 @ $89.32 · Sale (S): 9,689 @ $89.86 · Option exercise (M): 14,901 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,863 @ $24.55 · Option exercise (M): 16,863 @ $17.26 · Option exercise (M): 15,642 @ $27.09 · Option exercise (M): 15,086 @ $16.31 · Sale (S): 64,454 @ $75.91 · Sale (S): 47,621 @ $75.11 · +4 more | EDGAR |
| 2024-02-20 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,243 @ $0 · Tax withholding (F): 1,882 @ $65.82 · Option exercise (M): 4,583 @ $0 · Tax withholding (F): 2,033 @ $65.82 · Option exercise (M): 3,706 @ $0 · Tax withholding (F): 1,644 @ $65.82 · +6 more | EDGAR |
| 2024-02-16 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,362 @ $0 · Tax withholding (F): 1,935 @ $65.95 · Option exercise (M): 4,362 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 14,617 (derivative) @ $0 · Grant/award (A): 38,537 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 36,666 @ $0 · Tax withholding (F): 16,262 @ $0 | EDGAR |
| 2024-01-03 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 334 @ $0 · Grant/award (A): 847 (derivative) @ $0 | EDGAR |
| 2024-01-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 23,979 @ $0 · Tax withholding (F): 8,199 @ $57.81 · Option exercise (M): 23,979 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,863 @ $17.26 · Option exercise (M): 15,086 @ $16.31 · Option exercise (M): 13,661 @ $13.08 · Sale (S): 75,610 @ $46.64 · Sale (S): 30,000 @ $46.66 · Option exercise (M): 16,863 (derivative) @ $0 · +2 more | EDGAR |
| 2023-02-22 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,661 @ $0 · Tax withholding (F): 1,624 @ $46.23 · Option exercise (M): 3,661 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,243 @ $0 · Tax withholding (F): 1,250 @ $46.48 · Option exercise (M): 4,583 @ $0 · Tax withholding (F): 2,033 @ $46.54 · Option exercise (M): 3,706 @ $0 · Tax withholding (F): 1,644 @ $46.54 · +3 more | EDGAR |
| 2023-02-16 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 7,572 @ $7.39 · Option exercise (M): 4,153 @ $0 · Tax withholding (F): 1,219 @ $47.29 · Sale (S): 7,572 @ $47.14 · Option exercise (M): 4,153 (derivative) @ $0 · Option exercise (M): 7,572 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 14,901 (derivative) @ $0 · Grant/award (A): 17,449 (derivative) @ $0 · Grant/award (A): 45,404 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 318 @ $0 · Grant/award (A): 827 (derivative) @ $0 | EDGAR |
| 2023-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 13,134 @ $0 · Tax withholding (F): 4,042 @ $46.27 · Option exercise (M): 13,134 (derivative) @ $0 | EDGAR |
| 2022-11-28 | 4 | WATERS CORP /DE/ (WAT) | Grant/award (A): 54 @ $0 · Grant/award (A): 144 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | Nuance Communications, Inc. (NUAN) | Disposition to issuer (D): 4,519 · Disposition to issuer (D): 53,492 | EDGAR |
| 2022-03-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Sale (S): 11,029 @ $44.03 | EDGAR |
| 2022-03-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,481 @ $0 · Tax withholding (F): 1,988 @ $44.17 · Option exercise (M): 4,481 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 16,863 @ $17.26 · Option exercise (M): 15,086 @ $16.31 · Option exercise (M): 13,661 @ $13.08 · Option exercise (M): 7,572 @ $7.39 · Sale (S): 53,182 @ $42.75 · Grant/award (A): 23,979 (derivative) @ $0 · +4 more | EDGAR |
| 2022-02-23 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,661 @ $0 · Tax withholding (F): 1,624 @ $42.55 · Option exercise (M): 3,661 (derivative) @ $0 | EDGAR |
| 2022-02-22 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,583 @ $0 · Tax withholding (F): 2,033 @ $42.83 · Option exercise (M): 3,706 @ $0 · Tax withholding (F): 1,644 @ $42.55 · Option exercise (M): 4,583 (derivative) @ $0 · Option exercise (M): 3,706 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,153 @ $0 · Tax withholding (F): 1,219 @ $44.01 · Sale (S): 9,136 @ $43.47 · Option exercise (M): 12,187 @ $6.28 · Sale (S): 12,187 @ $43.70 · Option exercise (M): 4,153 (derivative) @ $0 · +3 more | EDGAR |
| 2022-01-04 | 4 | Nuance Communications, Inc. (NUAN) | Grant/award (A): 4,519 @ $0.00 | EDGAR |
| 2022-01-03 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 13,193 @ $0 · Tax withholding (F): 4,057 @ $42.48 · Option exercise (M): 13,193 (derivative) @ $0 | EDGAR |
| 2021-03-04 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Sale (S): 9,475 @ $38.84 · Sale (S): 12,127 @ $38.69 | EDGAR |
| 2021-03-02 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,481 @ $0 · Tax withholding (F): 1,988 @ $38.78 · Option exercise (M): 4,481 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 24,846 @ $7.16 · Sale (S): 24,846 @ $39.23 · Option exercise (M): 24,846 (derivative) @ $0 | EDGAR |
| 2021-02-23 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,661 @ $0 · Tax withholding (F): 1,624 @ $38.03 · Option exercise (M): 5,794 @ $0 · Tax withholding (F): 2,570 @ $39.20 · Option exercise (M): 3,661 (derivative) @ $0 · Option exercise (M): 5,794 (derivative) @ $0 · +1 more | EDGAR |
| 2021-02-19 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 3,706 @ $0 · Tax withholding (F): 1,644 @ $37.52 · Grant/award (A): 18,333 (derivative) @ $0 · Grant/award (A): 58,962 (derivative) @ $0 · Option exercise (M): 3,706 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 4,153 @ $0 · Tax withholding (F): 1,842 @ $38.39 · Option exercise (M): 4,153 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Grant/award (A): 16,195 @ $0 · Tax withholding (F): 6,720 @ $38.85 | EDGAR |
| 2021-01-06 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Sale (S): 17,083 @ $35.32 | EDGAR |
| 2021-01-05 | 4 | Nuance Communications, Inc. (NUAN) | Grant/award (A): 5,670 @ $0.00 | EDGAR |
| 2021-01-05 | 4 | BOSTON SCIENTIFIC CORP (BSX) | Option exercise (M): 24,479 @ $0 · Tax withholding (F): 7,396 @ $35.95 · Option exercise (M): 24,479 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1595612 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs